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Microbiology

Host-Parasite Interaction During Tularemia in the Mouse
Director:

J. Frederick Bell

The subject of host-parasite interaction during tularemia is
controversial. Uncertainites exist regarding the nature of the host
response to tularemic infection, and regarding the means by which the
etiologic agent causes disease. The purpose of this study was to
investigate the basis of these uncertainties and to attempt resolution
of them.
Although Francisella tularensis has generally been considered to
be a facultative intracellular parasite, the results obtained in this
investigation indicate that this organism is in extracellular association
with host mononuclear phagocytes during the disease process in the mouse;
and in this respect, may be unique among facultative intracellular
organisms. The following lines of evidence indicate an extracellular
nature of this organism with regard to mouse peritoneal macrophages:
1.) 2" tularensis strain Schu S4 was indifferent to the increased
bactericidal capacity of a BCG activated RES in the mouse, 2.) when
injected into the peritoneal cavity of mice, jF. tularensis became
associated with the fluid protion of the peritoneal exudate, whereas.
Listeria monocytogenes, when injected ip., became associated with the
cellular portion of the exudate, and 3.) fluorescent antibody staining
of macrophage cultures inoculated with
tularensis strain Schu S4,
did not reveal the presence of intracellular antigen.
Specific antibodies have been believed to have an insignificant
role in the expression of immunity to fully virulent tularemia
organisms. The results presented in this study do not support this
belief. The following lines of evidence indicate that antibodies may
be important in resistance: 1.) specific humoral immunity in combination
with a nonspecifically activated RES resulted in a degree of protection
against challenge with _F. tularensis strain Schu S4, 2.) ^^Cr-release
methodology showed that immune serum influenced the cytopathic effect
of 2' tularensis strain Schu S4 on cultured macrophages, 3.) pretreatment
of the organism with immune serum prior to ip. injection, increased
bacterial association with peritoneal cells, and 4.) immune serum
enabled cultured macrophages to suppress the growth of the organism in
cell cultures.
In the mouse, 2- tularensis strain Schu S4 may not ordinarily be
ingested by phagocytes, and may be able to overcome host defenses by
extraphagocytic proliferation and dissemination to sites of specific
target tissues. Resistance to infection appears to require the
synergistic cooperation of both humoral and cell-mediated immune
mechanisms. Specific antibodies control dissemination by promoting
phagocytosis, while specifically-sensitized macrophages destroy
ingested organisms by virtue of some specific altered, intrinsic
quality.
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CHAPTER I
INTRODUCTION

Francisella tularensls is a minute. Gram-negative, pleomorphic,
nonmotile, aerobic bacterium (16).

It was first isolated in 1912 by

McCoy and Chapin while investigating a plague-like disease among
ground squirrels in Tulare County, California (81).

In 1921, Francis

named this disease "tularemia" (45).
Tularemia is a zoonosis.

It is primarily a disease of wild

rodents and other small animals.
arthropod parasites.

It is also widespread among

Burroughs et al. (18) ha/e compiled a list of

48 naturally infected vertebrates.
and is usually a dead-end host.

Man is only incidentally involved

Man-to-man transmission is rare.

The disease can present itself in a variety of clinical forms.

In

animals, tularemia is often an acute, febrile and fatal disease,
however, subclinical infections and even chronic carrier states are
not uncommon.

In man, tularemia may be a protracted and debilitating

disease characterized byfwer, nausea, headache, malaise, chills and
enlargement of the lymph nodes, or it may be a subacute, inapparent
disease identified only in retrospect by serological procedures (96).
It is of the utmost importance to specify the virulence of the
particular strain of F^. tularensis whenever reference to the organism
is made.

Numerous strains of

their relative virulences (9).

tularensis exist which differ in
Strains of high virulence are such

that as few as 1 to 10 organisms may be sufficient to result in a
fatal infection of susceptible animals.

Strains of low virulence,
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even when administered in large qunatities, may be inocuous and
used as vaccines.

An accepted procedure for quantitation of the

virulence of 2- tularensis was set forth by Bell et al. (9).
Because various strains can be expected to react with hosts differ
ently, specification of virulence is, therefore, critical when
investigating host interaction with 2- tularensis.
Coupled with the high virulence of
infectivity of this organism.

tularensis is the high

R. R. Parker, as cited by Foshay (44),

related that he knew of no other disease of animals transmissible to
man by means so numerous and diverse.

Tularemia has ranked high on

the list of laboratory-acquired infections (98).
Infection may readily be initiated by contact with the organism.
F. tularensis has been reported to be able to wen penetrate the
unbroken skin (46,103).

Infected animals constitute a major source

of infection and serve to transmit the disease to those who may ingest
or come into contact with such sources, e.g. hunters, trappers, meat
processors, housewives (96,138).
Arthropods are vectors of infection for man and may also aid in
perpetuating the reservoir.

Fleas, flies, ticks and mosquitos have

been implicated as responsible for many reported cases of tularemia
in man (7,19,48,54).

It is of epidemiological interest that the

greatest incidence of tularemia in the United States in the fall and
winter months in noted in the Eastern region of the country, while
the greatest incidence of the disease in the Western region is noted
i n the spring and summer months.

These seasonal occurrences are

attributed to the popularity of rabbit hunting in the East and to
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the tick season in the West.
Another means by which the desease can be transmitted is by
drinking contaminated water (19,48,103).

Bell and Stewart have with

regularity, isolated _F. tularensis from streams in the Bitterroot
Valley of Western Montana.

The organism has been shown to remain

viable in natural waters for extended periods, especially in the
winter (10).

Infective water is another means by which the

reservoir is perpetuated.
Tularemia may also be contracted via the respiratory route (82).
Inhalation of dust from hay or straw contaminated with animal feces
often results in a pulmonary form of the disease (27).

An aerosol

created by the sneezing of an infected laboratory animal has
purportedly resulted in one known case of tularemia (Bell, personal
communication).
2" tularensis has been considered to be a member of the group of
organisms collectively referred to as facultative intracellular
parasites.

Such organisms are readily ingested by the phagocytic

cells of the reticuloendothelial system (RES).

They are able to

resist intraphagocytic destruction in nonimmune hosts.

Pathogenicity

is related to their ability to survive and proliferate within host
cells (122).

Other bacteria in this group include species of

Brucella, Listeria, Pasteurella, Mycobacterium, Salmonella and
Yersinia.
Resistance to intracellular infection is dependent on the
functional capacity of the host cells to inactivate the ingested
organism (77,80,125); a manifestation of acquired cellular immunity
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(86,87).

This type of immunity iwolves a complex interaction

between lymphoid cells in the host, and is most often achieved by
immunization with viable attenuated organisms (22,76).

Mackaness,

a pioneer in advancing the concept of cell-mediated immunity,
discovered that in mice, immunity to L. monocytogenes could be
passively transferred to naive recipients with viable spleen cells
from immune donors (79).

Numerous other studies have also shown

that immunity to intracellular organisms can be transE erred with
viable lymphoid cells (1,47,63,78,84,127,136).

The importance of

cellular factors in immunity to facultative intracellular parasites
is also indicated by an association between resistance and the state
of delayed hypersensitivity (DH) (21,23,28,63,77,123,124).

Acquired

cellular immunity and DH are thought to have similar or closely
related mechanisms (28,77,97).

Resistance to facultative intracell

ular parasites, however, has also been demonstrated in the absence
of DH (2,36,37,53,77,106,137).

The immunosuppressive effect of anti-

thymocyte globulin on immunity to numerous intracellular organisms
has implicated the thymus-dependent lymphocytes (T-cells) as being
the cell subpopulation mainly responsible for the state of acquired
cellular immunity (20,21,50,68,80,84).

A cell-mediated mechanism is

believed to be responsible for the state of acquired cellular immunity
to Brucella sp. (36,56,95), Listeria sp. (4,79),

enteriditis (92,109)

and S_. typhimurium (12,12,76).
Cell-mediated immune responses usually require the participation
of macrophages (52).

Macrophages may act as accessory cells and

function in the afferent arc of the immune response by processing
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antigens.

They may also function as an effector cell

iiNading organisms.

against

Macrophages are often the effector cell in the

immune response to facultative intracellular infections (108).

A

role for the mononuclear phagocyte was first postulated by
Metchnikoff in the late nineteenth century.

Since that time, much

evidence has accunulated which documents the importance of the
macrophage as the effector cell in the prevention of disease.

Passive

transfer of macrophages from resistant animals has been shown to confer
increased resistance to disease on normal recipients (1,118), while
the administration of antimacrophage agents to animals has been shown
to increase host susceptibility to infection (58,70,95,129).

Numerous

in vivo and in vitro investigation have demonstrated that the phago
cytes of immune animals have greater ingesti/e and digestive abilities
than cells from nonimmune donors (89,125,126).

Lurie (72,73) made

the initial observation that macrophages from rabbits immune to
tuberculosis ingested acid-fast bacilli at a greater rate than macro
phages from nonimmune animals; and that they could inhibit bacterial
growth when placed in the anterior chamber of the eye of a normal
rabbit.

Further work by Suter (121) showed that macrophages from

guinea pigs infected with Mycobacterium bovis strain BCG were able
to suppress the growth of tubercle bacilli in vitro.

Mackaness (74)

demonstrated that prior infection of mice with L. monocytogenes
enabled their peritoneal macrophages to resist intracellular growth
of the organism.

The time of appearance of the resistant macrophages

coincided with the disappearance of viable Listeria from the liv er
and spleen.

Thorpe and Marcus (125) reported that rabbit peritoneal
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macrophages, harvested from immunized animals, had greater cytopeptic
activities than did the counterpart cells from normal rabbits.

Ruskin

et al. (108) demonstrated that peritoneal macrophages harvested from
nonspecifically immunized mice were protected against neurotization
by bacterial and protozoal challenge.
In its role as an effector cell, the macrophage derives its
specificity from molecules liberated by specifically sensitized
T-cells after antigenic stimulation of those cells.

Interaction

between T-cells and macrophages in cellular immune responses is
mediated by these soluble substances which, in some unknown way,

alter the physiology of other cells.

Researchers have identified

and characterized a wide range of these lymphoid products (97).

The

elaboration of these soluble mediators by antigen-stimulated lympho
cytes is believed to be resposible for resistance to infection with
facultative intracellular parasites.
Host infection with facultative intracellular organisms often
results in the induction of nonspecific resistance.

Appropriate

stimulation of host cells may result in cross-protection against
infection with numerous organisms that have a predilection for intra
cellular existence (75,77,108).

Nonspecific stimulation can be

enacted by many types of intracellular infections (12,14,36,57,75)
and also by nonviable agents such as mycobacterial antigens (2,5,32),
lipopolysaccharides (15,100,107,115,135), simple lipids (25),
surfactants (26) or complement components (131).

Immunization of mice

with viable BCG has been shown to result in resistance against infection
with Brucella (120), Listeria (14) and Salmonella (111).

This
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phenomenon of heterologous resistance has been shown to extend beyond
phyiogenetic lines to include not only bacteria, but a number ot
protozoa (108), viruses (3,69) and neoplasms (67).

This wide range

d resistance is attributed to the activity of mononuclear phagocytes
which have increased microbicidal capacities that are not directed
exclusively against the original infecting organism (51,108).
Macrophages possessing such activity are commonly referred to as
being activated.

Such cells in vitro are morphologically distinct

from normal cells (14,75).

They appear larger than normal and have

increased invagination of their cell membrane.

They contain greater

than normal numbers of cytoplasmic digestive vacuoles and lysosomes.
They have elevated levels of oxidative and hydrolytic enzymes.
attach more readily to glass and spread more extensively.

They

The

ability of these cells to react nonspecifically indicates that a
common mechanism of immunity underlies intracellular infection.

This

mechanism has not been clearly defined.
Although there is little dispute that the effector cell responsible
for immunity to facultative intracellular organisms is the mononuclear
phagocyte, the role of specific antibodies in resistance is of
considerable controversy among investigators.

Some maintain that

immunity is primarily due to a change in the intrinsic properties of
the host cell and that antibodies are of only secondary importance in
host resistance (12,20,56,75,76,89).

Passive transfer of convalescent

serum has been shown, in many cases, to be ineffective in protecting
recipients against infection.

Organisms in an intracellular environ

ment are often shielded from humoral factors.

The fact that nonbact-
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erial substances are able to induce cross-protection against
facultative intracellular parasitic infection has been used as
supportive evidence for the contention that specific antibodies have
no significant role in resistance to infection by this type of organism.
Other investigators, however, argue that antibodies have an
important function in resistance to facultative intracellular parasites
(36,37,104,105).

Numerous in vitro studies have demonstrated that normal

and immune macrophages are capable of dealing with such parasites only
if immune serum is present in the culture medium.

Phagocytosis and

inhibition of growth is often less effective if specific antibodies are
not present.

Fong ^

(40,41) found that macrophages from BCG inoc

ulated mice were resistant to the cytopathic effect of virulent
tubercle bacilli only when serum from immune animals was present in
the culture medium.

Jenkin and Benaceraff (59) showed that pre-

treatment of virulent S^, typhimurium with immune serum increased the
rate at which the organisms were ingested and destroyed by macrophages
in vitro.

Jenkin and Rowley (60) reported that resistance to

S. typhimurium can be passively transferred with immune serum if
sufficient quantities were used.

Immune serum has been shown to be

required to prevent virulent B. melitensis from destroying normal
and immune phagocytes in vitro (36,37).
The subject of host-parasite interaction during tularemia is
controversial.

Uncertainties exist regarding the nature of the host

immune response to tularemic infection and regarding the means by
which the etiologic agent causes disease.
SGBxe, of the factors involved in immunity against tularemia appear
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similar to those which are important in resistance to other
facultative intracellular organisms.

Immunity can be passively

transferred to naive recipients with viable lymphoid cells from
immune donors, but not always with serum from such donors (1,108,118,
127,136).

Viable vaccines are generally more immunogenic than killed

vaccines (20,21,31,33,34,42,43,62,110,132).

The onset of immunity to

tularemia can be shown to coincide with the development of DH (20,21,
95) and the effector cell responsible for acquired immunity to this
organism is believed to the the macrophage (21,89,95).
Immunity to tularemia is, however, unlike immunity to other
facultative intracellular parasites in several interesting respects.
Resistance to tularemic infection is specific.

Claflin (20) and

Claflin and Larson (21) have shown that the induction of nonspecific
resistance in mice by immunization with viable BCG does not afford
protection against challenge with fully virulent tularemia organisms.
They have also shown that immunization with viable attenuated
F. tularensis induces no protection against subsequent challenge with
Z' novicida or

typhimurium.

It is unusual that this facultative

intracellular parasite is not only unaffected by nonspecific factors
of immunity, but that it is also unable to induce such nonspecific
immunity.

Further investigation of these findings would be substantiated.

The protective efficacy of viable vs
is an involved subject.

nonviable tularemia vaccines

To date, the only means of assuring maximum

immunity has been immunization with living organisms (20,24).

Russian

researchers were the first to report that living avirulent organisms
were more protective than killed preparations (128).

Since that time.

the superiority of live vaccines has been well documented (20,21,31,33,
34,42,43,62,95,110,132).

Protection from nonviable vaccines depends

on the natural susceptibility of the animal receiving the vaccine and
on the virulence of the challenge organism.

Killed vaccines have

been shown to be immunogenic in white rats (17,30,65) and also in
mice and guinea pigs if challenged with strains of less than full
virulence (8,42,66,90,93,113).

In general, nonviable antigenic

preparations are protective only 1.) in animals which have a degree
of natural resistance, and 2.) when strains of low or moderate
virulence are used as the challenge organism.

Explanations of the

underlying mechanism responsible for this variance in immunogenicity
are scanty.
Disagreement exists regarding the role of specific antibodies
in immunity to tularemia.

It has generally been held that antibodies

are only of secondary importance in the host response to tularemic
infection.

More recently, however, reports have appeared in the

literature which suggest that antibodies may assume an active and
important role in resistance.
contention that

These reports have also challenged the

tularensis is in intracellular association with

host phagocytes during the the disease process.

Further investigation

of this matter would be in order.
The _F. tularensis - mouse system provides a particularily
lucrative model for investigating host interactions with facultative
intracellular organisms.

There is little, if any, chance that

laboratory animals have been previously exposed to thes agent: an
important consideration when experimenting with Gram negative bacteria.
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Small numbers of organisms are sufficient to result in infection
and usually lead to an acute and fatal disease.

Endotoxin is not a

complicating factor in the pathogenesis of the disease.

Except for a

single report (64), no endotoxin-like material has been isolated or
boivin antigen detected (100,101).

Also, bacterial strains of

varying degrees of virulence are available to the researcher, as are
experimental hosts differing in susceptibility.

Statement of Problem
Francisella tularensis has generally been considered to be a
facultative intracellular parasite whose pathogenicity may be a
consequence of intraphagocytic multiplication.

Specific antibodies

have been considered to be only of secondary importance in host
resistance.

These beliefs have recently been challenged by reports

which suggest that F. tularensis may overcome host defenses primarily
by extraphagocytic growth and that antibodies may in fact, be essential
for host resistance.

The subject of host-parasite interaction during

tularemia remains an area of controversy.

This study was undertaken

to investigate the basis from which ambiguities have arisen and to
attempt resolution of them.

CHAPTER II
MATERIALS AED METHODS

Animals
Outbred Swiss-Webster mice between 4 and 8 weeks of age,
obtained from the colony at Rocky Mountain Laboratory, U.S. Public
Health Service, Hamilton, Montana, were used throughout this invest
igation.
Adult, New Zealand white rabbits, obtained from the above
institution served as the source of sera for cell culture media and
passive transfer studies.

All animals were allowed food and water

ad libitum.

Organisms
Strains of F^. tularensis were obtained in lyophilized form from
Dr. J. F. Bell, U.S. Public Health Service, Rocky Mountain Laboratory,
Hamilton, Montana.

The organisms were maintained on glucose cysteine

heart agar (Difco) supplemented with fresh defibrinated rabbit blood
to a final concentration of 5%.

tularensis strain Schu S4,

isolated by Foshay in 1941 is a strain of high virulence.

It has a

LD5Q of 1-10 colony forming units (CPU) in mice, guinea pigs and
rabbits. ]F. tularensis strain 425 F4G was isolated by Bell (9)
from a tick in Western Montana.

It is a highly virulent strain in

mice and guinea pigs (LD^g: I-J.0 CPU), but of lower virulence in the
rabbit.

The live vaccine strain (LVS), developed by Russian scientists

(128) and currently used in the United States as a live vaccine against
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tularemia, is of low virulence in mice (LD^g; 10^-10^ CFU).
Lyophilized lots of the various strains were established.

Periodically,

ampules were rehydrated and the contents cultured on glucose cysteine
blood agar (GCBA) plates (29,49).

Prior to use, the organisms were

reisolated twice from experimentally-infected mice to ensure full
virulence of the strain.
Suspensions of challenging or immunizing doses were prepared in
sterile physiological saline-gelatin solution (0.1% gelatin & 0.15% NaCl)
(sal-gel) from 24^48 hr cultures of the organism.

The suspensions were

adjusted to an appropriate concentration based on turbidometric readings
in the Klett-Summerson photoelectric colorimeter fitted with a #42 blue
filter.

Concentrations of viable organisms in suspension were

determined by standard plate counting techniques.

One-tenth ml

volumes of appropriate dilutions were plated on each of 3 GCBA plates
and incubated at 37 ®C for 24-48 hr.

Klett-250 suspensions (zero

dilution) of F^. tularensis routinely contained 10^-10^0 CFU per ml.
A culture of Mycobacterium bovis strain BCG-Paris was obtained
through the courtesy of Dr. C. L. Larson, Stella Duncan Memorial
Research Institute, University of Montana, Missoula, Montana.

The

organism was maintained as described below.
Cultures of I^. monocytogenes and

typhimurium were kindly

provided by Mr. Richard L. Hodinka, Department of Microbiology,
University of Montana, Missoula, Montana and maintained on TrypticaseSoy agar (Difco) plates at 4

C.

The organisms has mouse LD^g values

of 103'7 and 10^*^ CFU respectively.
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A culture of

novicida was obtained from the stock culture

collection at Rocky Mountain Laboratory, U.S. Public Health Service,
Hamilton, Montana, and maintained on GCBA plates.

This organism had

a mouse LD^Q of 10^"^ CPU.

Vaccines
Ether-extracted antigen (EEA) was prepared from 2- tularensis
strain Schu S4 according to the method of Larson (65).

Flasks

containing Snyders peptone broth (116) were inoculated with the
organism and incubated at 37 *C for 48 hr on a shaker.

Cells were

harvested by centrifugation at 8,000 x g for 30 min and washed 3 times
in sal-gel.

The sedimented cells were then resuspended in sal-gel and

treated with an equal volume of ethyl ether for 24 hr at room temp
erature with occasional shaking.

The ether phase was drawn off and

gaseous nitrogen passed through the aqueous phase to evaporate
residual ether.

The remaining solution, now designated EEA, has been

reported to be a crude suspension of pôlydisperse cell wall fragments
(90).

The suspension was then adjusted to a Klett reading of 100

with sal-gel and stored a 4 *C in sealed serum vials.

Absence of

viable organisms was confirmed by plate culture and by mouse inoc
ulation.

An immunizing dose consisted of 0.2 ml, and was injected

into â tail vein of the mice.

Antigenicity was confirmed by a

positive capillary tube precipitation reaction and by titer determ
inations on injected animals.
Viable BCG was prepared according to a protocol maintained at
the Stella Duncan Memorial Research Institute, University of Montana,
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Missoula, Montana.

Flasks of Dubos medium (Difco) were inoculated

with Mycobacterium bovis strain BCG-Paris, from a culture maintained
on Hohns medium (Difco). The cultures were incubated at 37

for

7-9 days, passed to fresh Dubos medium and allowed to incubate
another week.

The cells were then harvested by centrifugation at

4,080 X g for 30 min and washed 3 times in Dubos medium.

The cells

were resuspended in Dubos medium and adjusted to a density of 200
Klett units.

The vaccine was stored at -70

in sealed serum vials.

Purity was checked by Ziehl-Nielson acid-fast staining.

The working

vaccine was readied by diluting the suspension 1:1 with Dubos medium.
A standard immunizing dose of 0.2 ml was injected into a tail vein of
the mice.

This amount corresponded to approximately 250^g wet weight

of bacteria and 7 x 10^ CFU.

Efficacy of this vaccine was tested by

injecting groups of mice and 3 weeks post^injection, determining the
presence of 1.) splenomegaly, 2.) delayed hypersensitivity to
purified protein derivative (PPD), and 3.) nonspecific resistance.

Serologic tests
Bacterial agglutination titers were conducted on serum samples
according to standard tube agglutination procedures.

A stock

suspension of formalin-killed _F. tularensis strain 425 F^G was
prepared (approximately 1 x 10^ cells per ml) and used as the
agglutinogen.

The stock suspension was diluted 1:300 to obtain the

working solution.

Serial 2^ fold dilutions (0.5 ml) were made for each

serum sample with saline, and equal volumes of the agglutinogen were
added to each tube.

The agglutination titer was determined as the
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reciprocal of the highest dilution of serum showing positive
agglutination after overnight incubation at 37 "C.

Passive transfer of sera
New Zealand white rabbits were injected sc. with approximately
1 X 10^ viable F^. tularensis strain Schu S4 organisms and streptomycin
therapy was initiated 3 days later (daily im. injections of 200 mg
streptomycin sulfate for

5

days).

When recovery was assured, the

rabbits were anesthesized with sodium pentobarbital and exsanguinated.
Sera were separated and pooled.

Volumes of 0.5 ml were injected into

a tail vein of the recipient mice 1 hr before bacterial challenge and
again at 1 hr after challenge.

Protection tests
Protection against a challenge infection was measured in terms
of survival after injection with serial 10-fold dilutions of challenge
organism into separate groups of mice.

Experimental and control

groups of 10-15 mice each were injected sc. with 0.5 ml of each
dilution.
days.

Deaths among challenged mice were recorded daily for 14

The LD^g

and the mean time to death (MTD) were calculated for

each group.

In vitro studies
Mouse peritoneal adherent cells were used in
experiments to host-parasite interaction.

vitro correlate

To collect the cells, mice

were killed by cervical dislocation and injected ip. with 5.0 ml of
Dulbecco's phosphate buffered saline (PBS) containing 5 units of
heparin per ml.

Eliciting agents or irritants were not used to obtain
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higher yields of cells because it has been demonstrated that results
will vary with different elliciting agents (24,38,83).

After gentle

kneading of the abdomen, the surrounding skin was swabbed with 70%
ethyl alcohol and reflected back.

The peritoneal sac was punctured

aseptically and the enclosed fluid was allowed to drain into sterile,
cold, siliconized, glass centrifuge tubes.
discarded.

Bloody exudates were

Following centrifugation at 500 x g for 5 min, the

supernatant fluid was discarded.

Sedimented cells were washed 3

times in Dulbecco's PBS + heparin, treated with Tris-NH^Cl for 10 min
at room temperature and washed again.

The cells were then suspended

to the desired seeding concentration in cell culture mainenance
medium (RPMI supplemented with 20% heat inactivated rabbit serum,
200 unit s/ml penicillin and 2.5 /<g/ml fungizone).

Cell suspensions

were placed in appropriate culture vessels and allowed to incubate for
45 min at 37

in a 5% CO2 atmosphere.

The cultures were then washed

to remove nonadherent cells.
The in vitro experimental setup (Fig. 1) was designed to
correlate with antecedent in vivo experiments.

Two variables existed;

1.) the immune status of the macrophage source, and 2.) the type of
serum present in the cell culture medium.

The cell cultures were

inoculated with F^. tularensis strain Schu S4 and two parameters were
investigated; 1.) the fate of the macrophages, and 2.) the fate of the
inoculum.

In vitro cytopathology assays
Cell count method - Mouse peritoneal macrophages were cultured in
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Inoculated with
F. tularensis-Schu S4 1

Peritoneal
macrophages
harvested
from normal
mice

Peritoneal
macrophages
harvested
from BCG immune
mice^

Peritoneal
macrophages
harvested from
specifically ^
immunized mice"

Fig. 1.

Noninoculated
controls

Normal rabbit
serum in medium

O

£]

p

Immune rabbit
serum in medium

10

Normal rabbit
serum in medium

O

jC
to

Immune rabbit
serum in medium

Normal rabbit
serum in medium

o

Immune rabbit
serum in medium

Experimental setup used in determining the effect of
macrophage source and specific antibody on macrophage
viability and bacterial growth in cell cultures
inoculated with F. tularensis strain Schu S4.

^Cultures were inoculated at a ratio of approx. 10 bacteria/macrophage.
^Mice were immunized iv. with viable BCG (7 x 10^ CFU, 250/4 g ^et wt)
3 weeks prior to harvesting of macrophages.
^Mice were given a 1^ injection sc. of approx. 10^ viable LVS organisms
and a 2® injection 2 weeks later of approx. 10^ viable Schu S4 organisms.
Macrophages were harvested 3 weeks after 2® injection. GCBA plate
cultures of harvested cells at this time yielded no viable bacteria.
^Serum was obtained from rabbits which had been injected sc. with approx.
10^ viable Schu S4 organisms and treated with streptomycin (daily im.
injections of 200 mg streptomycin sulfate, initiated 3 days post-injection).
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Lab-Tek* cell culture chamber slides.

Prior to seeding of the cells,

circles of approximately 1 mm in diameter were etched on the surface
of the glass floor of each culture chamber by means of a diamondpoint pencil and a template.

The etching fragments were removed and

the cell culture chamber slides were disinfected by UV irradiation.
Macrophage cultures were established in the chambers.

Photomicro

graphs were made of the cells contained within the inscribed area
of the chamber with a Nikon

model F2 inverted microscope coupled to

a polaroid photoattachment adapter cone fitted with a 1.3X lens and
a 4" X 5" type 55 PN back and an AFM exposure control.

Macrophage

cultures were inoculated with %. tularensis strain Schu S4 at a
ratio of approximately 10 bacteria per macrophage.

Photomicrographs

of the circumscribed cells were made daily for 7 days.

Cultures

were washed before photographing to remove cells which had become
nonadherent.

Cell counts were conducted on the photomicrographs,

and the decrease in the number of viable, adherent cells was recorded.
51cr-release method - Mouse peritoneal exudate cells were
harvested and processed as previously described.

The cells were

incubated in the presence of radioactive Na2^^CrO^ at a concentration
of approximately lOOyyci/lO^ macrophages in a 37 ®C water bath for
30 min with occasional shaking.

After 3 washings in cold RPMI medium

to remove nonincorporated label, the cells were resuspended in RPMI
medium and seeded at a concentration of approximately 10^ cells per ml.
in plastic screw-top test tubes.

Following an incubation period of

45 min, the nonadherent cells were removed by washing.

Radioisotopic

counts were made after withdrawing the culture medium and inserting
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the culture vessel into a Nuclear

model 8775 gamma counter.

medium was replaced after the readings.
inoculated with

Culture

Macrophage cultures were

tularensis strain Schu S4 and counts of the

radioactivity remaining in the adherent cells were made at 12 hr
intervals for 5 days.

Background radiation was counted and recorded.

Cytopathology was measured by determining the rate at which the
label was released from the adhered macrophages.

In vivo phagocytosis of bacteria by mouse peritoneal cells
In vivo phagocytosis of 2- tularensis and L. monocytogenes by
mouse peritoneal cells was determined by the method of Taplits and
Myrvik (124).
5 mice each.

Bacterial suspensions were injected ip. into groups of
One hr after injection, the peritoneal cavities were

las/aged and the exudates were centrifuged in siliconized centrifuge
tubes at 480 x g for 5 min.

Cell-associated and supernatant-

associated bacteria were assayed by plating serial dilutions of the
respective fractions.

The data are presented as the percent of the

total bacteria recovered.

Immunofluorescence

Fluorescein isothiocyanate-conjugated antitu larensis immuno
globulin had been prepared by Mr. Scott J. Stewart, Rocky Mountain
Laboratory, U.S. Public Health Service, Hamilton, Montana, according
to the method of Peacock, et al. (94), and was used to stain
macrophages from cultures which had been inoculated with IF. tularensis.
Macrophage cultures were inoculated with 2- tu larensis at a ratio of
approximately 50 bacteria per macrophage.

The cells were incubated

21
until cytopathology was first noted.

The cultures were then washed,

and the cells were fixed in acetone at -70

for at least 12 hr.

The cells were stained as described in a protocol by Bell (unpublished)
and viewed in a Leitz-Wetzlar Ortholux Il/Diayert fluorescent
microscope equipped with a 35 mm Orthomat W camera.
controls were included.

Appropriate

CHAPTER III
RESULTS

Attempt to induce nonspecific imnunity to F. tularensis strain Schii S4
This study stemmed from the finding by Claflin and Larson (21)
that immunization of white mice with viable BCG afforded no crossprotection against subsequent challenge with 2» tularensis strain Schu
S4.

Viable BCG, when administered to animals, typically results in

nonspecific stimulation of the recipients' RES.

Such stimulation has

been shown to be effective in inducing protection against infection
with numerous etiologic agents.

It appeared unusual that 2* tularensis

should be virtually unaffected by nonspecific factors of immunity.
A preliminary experiment was conducted to confirm this earlier
finding of Claflin and Larson (21).

Groups of mice were injected iv.

with viable BCG (7 x 10^ CFU, 250/(g wet wt).

After a period of 3

weeks, when nonspecific resistance was at its height (D. Lodmell and
C. L. Larson, unpublished data), groups of mice were challenged sc.
with serial 10-fold dilutions of

tu larensis strain Schu S4.

At

this time, it was determined that the inoculated mice had a 4.7X
splenomegaly compared to noninoculated controls.
strate DH to PPD were unsuccessful.

Attempts to demon

Separate groups of mice were also

challenged with serial 10-fold dilutions of
typhimurium, and with 2- novicida.

monocytogenes,

Table I shows that inoculation

of mice with viable BCG did not result in protection against challenge
with IF. tularensis strain Schu S4.

Results shown in Table II indicate

that this BCG vaccine was capable of inducing nonspecific resistance.
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Table I. Attempt to Induce nonspecific resistance to sc. challenge
with 2" tularensis strain Schu S4 in mice immunized 3 weeks previously
with viable BCG (7.0 x 10^ CFU, 250)i(g wet wt) injected iv.

Number of
challenge
organisms
(CFU)

d/t*

loi

10/10

10^

10/10

5.0

10^

Control mice

BCG immunized mice

d/t

MTD

5.7 ± 0.7

10/10

5.1 ± 0.6

+

0.7

10/10

5.0 ± 0.0

10/10

4.5 ± 0.5

10/10

4.5 ± 0.5

104

10/10

4.3 ± 0.7

10/10

4.1 ± 0.6

10^

10/10

4.1 ± 0.3

10/10

4.1 ± 0.3

10^

10/10

4.2 ± 0.5

10/10

4.0 ± 0.0

10?

10/10

3.8

+

0.8

10/10

3.1 ± 0.7

10®

10/10

3.5

+

0.5

10/10

3.1 ± 0.6

LD30

MTD^

< loi

LogSjQ protection

^Deaths per total mice challenged.
^ean time of death (days) ± S.E.

< loi

0

Table II. Ability of viable BCG to induce nonspecific resistance to sc.
challenge with I,, monocytogenes,
typhimurium and
novicida*.

Challenge organism
Number of
challenge
organisms
(CFU)

L. monocytogenes
Control

BCG Immune

S. typhimurium
Control

BCG Immune

F. novicida
Control

BCG Immune

10^

0/5%

0/5

1/5

0/5

0/5

0/5

102

1/5

0/5

3/5

0/5

3/5

0/5

10^

3/5

0/5

4/5

1/5

3/5

0/5

10^

2/5

1/5

5/5

3/5

4/5

0/5

105

4/5

0/5

5/5

3/5

5/5

0/5

10^

4/5

0/5

4/5

3/5

5/5

1/5

107

5/5

1/5

5/5

5/5

4/5

3/5

108

5/5

2/5

5/5

5/5

5/5

4/5

103.7

>108.0

102.0

104.4

102-7

106.8

LD50
togs^o protection

> 4.3

2.4

4.1

*Mice were challenged sc. 3-weeks after iv. injection, of viable BCG (7.0 x ID^ CFU, 250 /(g wet wt).
^Deaths per total mice challenged»
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Effect of BCG immunization on inf ection with IF* tularensis strains of
reduced virulence

Highly virulent 2- tularensis strain Schu S4 has been shown to
be unaffected by nonspecific factors of immunity.

It was desired

to know whether this finding applies to 2' tu larensis strains of
reduced virulence.

The preceeding experiment was repeated using

2" tularensis strain 425 F^G and strain LVS as the challenge organisms.
Data presented in Table III show that nonspecific activation of the
RES resulted in a degree of protection against the strains of reduced
virulence.

Although BCG immunization did not protect against mortality

in mice challenged with IF. tu larensis 425 F^G, a significant increase
in the mean time of death was noted.

Protection against challenge

with 2* tularensis strain LVS was manifest as both a decrease in
mortality and an increase in the mean time of death of the fatalities.
Coupled with the results presented in Table I, it can be observed
that the degree of protection against tularemic infection, attributable
to RES activation, is inversely related to the virulence of the
particular infecting strain.

Subsequent investigation will be centered

primarily on host interaction with F. tularensis strain Schu S4.

Table III. Protective effect of immunization with viable BCG on mice challenged sc. with F^. tularensis
strain LVS and strain 425 F^G®.

Strain of F. tularensis
Number of
challenge
organisms

425 f4g

LVS
Control
d/tb

BCG immune

MTDC

d/t

BCG immune

Control

MTD

d/t

MTD

d/t

MTD

0/10

-

0/10

-

10/10

6.4 ± 0.5

10/10

8.8 ± 0.8

102

0/10

-

0/10

-

10/10

6.2 ± 0.4

10/10

8.1 ± 1.2

103

3/10

7.6 ± 0.6

0/10

-

10/10

5.8 ± 0.4

10/10

104

8/10

6.3

+

0.9

0/10

-

10/10

5.4 ± 0.7

10/10

7.2 ± 1.8

105

10/10

6.4

+

1.0

0/10

-

10/10

5.1 ± 0.3

10/10

6.9 ± 1.3

10^

10/10

5.0

+

0.8

4/10

6.8 ± 0.5

10/10

4.5 ± 0.7

10/10

5.8 ± 1.2

10^

10/10

4.4

+

0.8

9/10

5.1 ± 0.6

10/10

4.2 ± 0.4

10/10

6.6 ± 1.6

10®

10/10

4.2

+

0.8

10/10

4.7 ± 0.5

10/10

3.7 ± 0.3

10/10

5.6 ± 1.4

Logsio protection

10^.4

106.2
2.8

0
1—r
0
1—f
v

ld50

1+
00

10^

1.0
< 10
0

^Mice were challenged sc. 3 weeks after iv. injection of viable BCG (7 x 10^ CFU, 250^g wet wt).
^Deaths per total mice challenged.
^Mean time of death (days) ± S.E.

1.2
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The combined effect of specific humoral immunity and nonspecific RES
activation on resistance of mice to . tularensis strain Schi S4
C. L. Larson (personal communication) suggested that a BCG
activated RES might require the presence of specific antibodies for
the expression of resistance to infection with fully virulent strains
of

tularensis.

In the following 2 experiments, the combined effect

of specific antibodies and BCG immunization on the resistance of mice
to 2' tularensis strain Schu S4 was determined.

A humoral response

was established by: 1.) active immunization with a bacterial antigen,
or 2.) passive administration of immune serum.

Experiment
- Specific active immunization with EEA combined with
nonspecific RES activation by viable BCG.
Groups of mice were injected with EEA, BCG or both.

Mice were

inoculated with 0.2 ml of a Klett-100 suspension of EEA, followed by
a similar injection 2 weeks later.

Agglutination tests with a

F. tularensis antigen revealed that the response of the mice to EEA
was highly variable (Table IV).

Mice inoculated with EEA were

challenged sc. with serial 10-fold dilutions of _F. tularensis strain
Schu S4 1 week after the second inoculation.

To investigate the

combined effect of a specific and nonspecific vaccine, mice, which
had been inoculated with a primary dose of EEA 2 weeks previously,
were injected iv. with a Klett-200 suspension of viable BCG that had
been diluted 1:1 with a Klett-100 suspension of EEA.

The mice were

challenged 3 weeks later as described above.
The results from a typical experiment are shown in Table V and
Fig. 2.

None of the immunization regimes resulted in protection against
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Table IV. Antibody response of mice to primary and secondary
Immunization with EEA^.

Agglutination titer
Sample
number

1
2
3
4
5
6
7
8
9
10

2 weeks post-1* Injection

<4
8
8
<4
4
4
<4
8
4
4

1 week post-2* Injection

16
128
4
32
32
64
128
128
64
32

®Mlce were Injected Iv. with 0.2 ml of a Klett-100 suspension of EEA
and reinjected 2 weeks later with an equal dose.

Table V. Effect of specific immunization with EEA and nonspecific immunization with viable BCG on
mice challenged sc. with serial 10-fold dilutions of F. tularensis strain Schu S4,

Treatment
EEA
organisms

d/t'

mtd'

BCG

EEA & BCG

d/t

mtd

d/t

mtd

d/t

MTD

10^

10/10

+ 0.6
5.1 ±

10/10

± 1.2
6.3 +
1.2

10/10

+ 0.7
5.7 ±

10/10

10.2 +
± 1.8

102

10/10

5.0 +
± 0.0

10/10

5.4 ± 0.8

10/10

5.0 +± 0.7

10/10

+ 1.1
7.9 ±

10^

10/10

4.5 +
± 0.5

10/10

5.0 ± 0.7

10/10

± 0.5
4.5 +

10/10

7.3 ±+ 1.4

104

10/10

+ 0.6
4.1 ±

10/10

5.1 ± 0.9

10/10

4.3 +± 0.7

10/10

+ 0.9
6.9 ±

105

10/10

4.1 ± 0.3

10/10

+ 1.6
4.9 ±

10/10

+ 0.3
4.1 ±

10/10

6.1 ±+ 0.3

10^

10/10

4.0 +± 0.0

10/10

4.8 ± 0.8

10/10

± 0.5
4.2 +

10/10

6.4 +
± 0.7

10?

10/10

3.1 ±+ 0.7

10/10

3.8 ±+ 0.9

10/10

+ 0.8
3.8 ±

10/10

6.2 +
± 0.8

10®

10/10

+ 0.6
3.1 ±

10/10

3.7 ± 0.8

10/10

+ 0.5
3.5 ±

10/10

5.1 ±+ 0.6

LD50

< 10^

^Deaths per total mice challenged,
^ean time of death (days) ± S.E.

<ior

<10^

< lOl

I

102

I

103

I

1

I

105

NUMBER OF CHALLENGE

106

I

io7

I

io8

ORGANISMS

Effect of specific immunization with EEA and nonspecific immunization with viable
BCG on the mean time of death of mice challenged sc. with serial 10-fold dilutions
of 2* tularensis strain Schu S4. Normal mice O
o ; EEA immune mice •
•;
BCG immune mice #
# ; EEA and BCG immune mice A
—A •
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mortality.

Specific active immunization in combination with

nonspecific immunization with viable BCG, however, resulted in a
low order of protection as expressed by a statistically significant
increase in the mean time of death of the challenged mice.

Experiment 2. - Passive transfer of immune serum combined with
nonspecific RES activation by viable BCG.
As in Experiment 1, four experimental groups existed: 1.) an
immunologically naive, control group of mice; 2.) a group of mice
with specific circulating antibodies; 3.) a group of mice which had
a BCG activated RES; and 4.) a group of mice with both specific
humoral antibodies and a nonspecifically activated RES.

Immune

rabbit serum (agglutination titer: 1024) was injected in 0.5 ml
amounts into a tail vein of recipient mice 1 hr before challenge with
serial 10-fold dilutions of _F. tularensis strain Schu S4, and again
at 1 hr after challenge.

Normal rabbit serum was likewise injected

as a control into appropriate recipient groups.

To investigate the

combined effects of specific antibodies and a nonspecifically
stimulated RES, sera were passively transferred to recipient mice
which had been inoculated 3 weeks previously

with viable BCG.

The

rate of clearance of rabbit antibodies from recipient mice was
determined (Table VI and Fig. 3).
The results presented in Table VII and Fig. 4 essentially
parallel the results of the previous experiment.

None of the

immunization regimes protected against mortality, however, degrees
of protection were detected by observing the mean time of death of
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Table VI. Antitularensis titer determinations on mice, following
passive transfer of Immune rabbit serum^.
Sampling time^
0
3
6
12
1
2
3
4
5
6
7
8

Agglutination titer

hr

512
512
512
256
256
256
128
128
128
128
128
64

hr
hr
hr
day
day
day
day
day
day
day
day

^Mice were injected iv. with two 0.5 ml volumes of rabbit antitularensis
serum, separated by a 2 hr interval (agglutination titer; 1024).
^Time 0 hr; immediately following second serum injection.

600 -I

1

2

3

4
TIME

Fig" 3.

5

6

7

8

(days)

Clearance of rabbit antitularensis immunoglobulin from recipient
mice. Mice were injected iv. with two 0.5 ml volumes of rabbit
antitularensis serum (separated by a 2 hr interval). Time 0;
immediately following second serum injection. Titers were
determined on sera pooled from 5 mice per sampling time.
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of the fatalities.

There was a slight degree of protection noted

among the group of normal mice receiving immune serum attributable
to the effect of the specific antibodies.

RES activation alone

resulted in no significant deviation from control values.

Specific

antibodies in conjunction with nonspecific RES activation afforded
the greatest degree of protection to the challenged mice as
revealed by prolongation of survival.

Table VII. Effect of passive transfer of immune rabbit serum and nonspecific immunization with viable
BCG on mice challenged sc. with serial 10-fold dilutions of F. tularensis strain Schu S4.

BCG immune mice
Immune serum

Normal serum

Immune serum

MTD^

d/t

MTD

d/t

MTD

d/t

MTD

10/10

5.4 +
± 0.5

10/10

8.2
8 . 2 +± 0.8
0.8

10/10

+ 0.7
6.6 ±

10/10

11.8 ±+ 2.4

10^

10/10

5.0 +
± 0.7

10/10

± 0.6
7.6 +

10/10

+ 0.6
5.6 ±

10/10

10.8 ±+ 1.9

103
10-

10/10

4.6 +
± 0.9

10/10

± 0.5
7.2 +

10/10

+ 0.5
5.8 ±

10/10

8.6 +± 1.8

10^
10^

10/10

4.2 +± 0.5

10/10

1.1
6.6
6 . 6 ±+ 1.1

10/10

4.6 +
± 0.6

10/10

8.0 +
± 1.2

105
10-

10/10

4.2 +± 0.5

10/10

5.4 +± 0.6

10/10

5.0 +
± 0.0

10/10

+ 1.1
7.8 ±

10":

OV
0
1—1

10/10

4.0 ±± 0.0

10/10

+ 0.5
5.8 ±

10/10

4.0 +± 0.7

10/10

7.0 +± 1.4

10?
10'

10/10

3.2 +± 0.5

10/10

4.8 ± 0.8

10/10

± 0.5
4.2 +

10/10

6.4 +
± 1.1

10=
10®

10/10

3.0 ± 0.0

10/10

5.0 ± 0.0

10/10

+ 0.6
3.6 ±0.6

10/10

6.7 ±+ 1.0

challenge
organisms

d/t'

10^

LD50

<10l

^Deaths per total mice challenged.
%ean time of death (days) ± S.E.

<10l

<10^
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Effect of passive transfer of immune rabbit serum and nonspecific immunization with
viable BCG on the mean time of death of mice challenged sc. with serial 10-fold
dilutions of jP. tularensis strain Schu S4. Normal mice, normal serum O
O;
normal mice, immune serum •
•; BCG immune mice, normal serum e
e;
BCG immune mice, immune serum A
A «
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In vitro correlates to host-parasite interaction
The preceeding
results.

vivo studies produced unusual and interesting

Rirther investigation was conducted in vitro in order to

obtain more experimental control over this host-parasite system.
Macrophages were used as the cell type in this

vitro system

because it is generally believed that the prime mediator of protection
against facultative intracellular bacterial infections is a cellular
immune mechanism residing in the macrophage population.
Differential cell counts, conducted on Wrights and Giemsa
stained cell cultures, revealed that the cell population, as
determined by morphological criteria, consisted of greater than 95%
mononuclear leucocytes (Fig. 5).

Functional testing by latex

particle ingestion showed that greater than 95% of the cells were
phagocytic (Fig. 6).

It is with these qualifications that the cells

are referred to as macrophages.

Experiment 1. - Determination of macrophage viability via cell counts
after inoculation of cultures with 2- tularensis strain Schu S4,
Cell counts of adherent (viable) macrophages were conducted
daily on photomicrographs of cells which were contained within etched
areas on the culture vessel floors.

A typical photomicrograph, from

which counts were made, is presented in Fig. 7.

Cell counts were

made with the aid of an acetate sheet overlay and a marking pen.

The

mmber of cells adherent within the enscribed area was monitored for
5 days.
Results are shown in Table VIII and Fig. 8-10.

This particular

assay method apparently lacked sensitivity as evidenced by deviations

in cell counts and by wide fluctuations in the slope of the
corresponding graphs.

The assay was not repeated an adequate number

of times to determine the standard error because of reason presented
below.
made.

Conclusions from the results of this experiment were not
The results do, however, evoke inferences that 2- tularensis

strain Schu S4 had a cytopathic effect on macrophages

harvested

from normal and BCG immunized mice, but not on macrophages harvested
from mice specifically immunized with viable tularemia organisms.
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Fig. 5.

Mouse peritoneal adherent cells maintained in RPMI
medium containing 20% rabbit serum, and stained by
a modified Giemsa method. 2000X.

Fig. 6.

Mouse peritoneal adherent cells maintained in RPMI
medium containing 20% rabbit serum, 5 min after
inoculation with 1.0/<m diam. polystyrene latex
particles, and stained by a modified Giemsa method.
2000X.
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40

%

PI
Fig. 7.

Mouse peritoneal adherent cells maintained in RPMI medium
containing 20% rabbit serum, as they appeared at time
of challenge, with delineated area etched in the floor
of the culture vessel. 50X.

Table VIII. Effect of 2- tularensis strain Schu S4 on the viability of macrophages of various immune
status, cultured in medium containing normal vs immune rabbit serum.

Macrophage
source

Type of
rabbit serum

12

3

4

Normal

Control
Inoculated

1,507®
1,694

1,403
1,385

1,426
882

1,310
729

1,273
702

1,256
676

Immune

Control
Inoculated

1,618
1,550

1,515
1,264

1,355
1,056

1,429
584

1,504
699

1,467
572

Normal

Control
Inoculated

1,708
1,420

1,363
1,021

1,208
826

1,472

688

1,361
838

1,377
641

Immune

Control
Inoculated

1,575
1,625

1,654
1,694

1,351
972

1,440
615

1,299
392

1,223
327

Normal

Control
Inoculated

1,599
1,437

1,422
1,344

1,457
1,407

1,329
1,250

1,198
1,037

1,133
969

Immune

Control
Inoculated

1,537
1,667

1,207
1,595

1,443
1,526

1,381
1,603

1,337
1,550

1,235
1,474

Nonimmunized
mice

BCG immunized
mice

Specifically
immunized
mice

Days post-inoculâtion

Experimental
group

%umber of macrophages adhered within delineated area.
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Fig. 8.

Viability of normal mouse peritoneal macrophages, cultured
in medium containing normal vs immune rabbit serum, and
inoculated with F. tularensis strain Schu S4. Inoculated • ;
noninoculated o ; normal serum in medium
; immune
serum in medium •
.
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Viability of macrophages from BCG immunized mice, cultured
in medium containing normal, vs immune rabbit serum, and
inoculated with
tularensls strain Schu S4. Inoculated • ;
noninoculated o ; normal serum in medium
; jjnmune
serum in medium •••
.
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Viability of macrophages harvested from mice specifically
immunized with viable 2- tularensis, cultured in medium
containing normal vs immune rabbit serum, and inoculated
with 2» tularensis strain Schu S4. Inoculated •;
noninoculated o ; normal serum in medium
; immune
serum in medium
•
.
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Experiment 2. - Determination of macrophage cytopathology via ^^Crrelease after inoculation of cultures with _F. tularensis strain Schu S4.
The previous cell count method for determining the effect of
Z* tularensis strain Schu S4 on cultured macrophages was considered to
be excessively crude.

A quicker, simpler, more sensitive and more

reproducible method for assaying cytopathology was applied, viz ^^Crrelease.
Cultures of ^^Cr-labelled macrophages were inoculated with
2' tularensis strain Schu S4 at a ratio of approximately 10 bacteria
per macrophage.

The amount of label released from the cells was

monitored at 12-hr intervals fro 5 days by removing the culture
medium, inserting the culture vessel into a gamma counter and
measuring the amount of radioactivity emitted.
Tables IX-XII and Fig. 11-13 show the effect of the various
macrophage source/sera combinations on macrophage cytopathology.

The

loss of label from cells in noninoculated cultures is due to the natural
permeability of the macrophage cell membrane and to radioisotopic decay.
Divergence in the rate of 51cr-release between control and
inoculated cultures indicates that £. tularensis strain Schu S4 had a
cytopathic effect on macrophages harvested from normal and BCG immunized
mice.

This divergence was not noted among macrophages harvested from

mice which were specifically immunized with viable F. tularensis.
The presence oE immune serum in the culture medium did not mitigate
macrophage cytopathology.

In fact, specific antibodies increased the

susceptibility of normal and activated macrophages to bacterial
destruction.

This increase of susceptibility was greater among

activated macrophages.
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Table IX, Effect of
tularensis strain Schu S4 on the release of ^^Cr
from normal mouse peritoneal macrophages cultured in medium containing
normal vs immune rabbit serum.

Normal
serum
Hours postinoculation
0
12
24
36
48
60
72
84
96
108
120

Control

Immune
serum

Inoculated
97,109
80,256
72,591
65,204
53,937
40,349
29,381
24,277
22,137
19,642
16,335

104,747*
83,081
75,994
69,087
63,892
59,191
55,964
54,154
51,317
47,163
42,977

Control
105,864
82,918
73,597
66,270
60,683
57,126
52,903
49,867
48,372
46,229
42,326

Inoculated
103,841
83,443
75,994
59,747
43,767
29,239
20,548
16,976
15,016
11,799
8,823

^CPM remaining in adhered macrophages•

Table X. Effect of _F. tularensis strain Schu S4 on the release of ^^Cr
from macrophages harvested from BCG immunized mice, and cultured in
medium containing normal vs immune rabbit serum^

Normal
serum
Hours postinoculation

Control

0
12
24
36
48
60
72
84
96
108
120

165,297*
128,317
109,759
100,629
91,432
85,694
79,453
78,124
76,863
73,149
69,588

Inoculated

162,011
131,764
116,722
105,432
91,503
66,732
42,825
34,075
30,861
27,102
22,914

^CPM remaining in adhered macrophages.

Immune
serum
Control

231,215
189,477
162,754
145,464
131,813
119,684
105,326
102,305
100,876
98,347
94,166

Inoculated

233,248
188,216
154,365
112,699
61,496
35,835
24,330
21,436
18,426
14,872
11,003
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Table XI. Effect of
tularensis strain Schu S4 on the release of ^^Cr
from macrophages harvested from mice specifically immunized with
_F. tularensis, and cultured in medium containing normal vs immune rabbit
serum.

Normal
serum
Hours postinoculation
0
12
24
36
48
60
72
84
96
108
120

Control
123,134*
90,797
83,910
73,605
66,970
62,426
59,116
56,327
52,712
48,223
45,271

Inoculated
136,005
100,974
93,141
83,750
75,786
68,831
64,247
60,823
56,952
51,263
47,030

^CPM remaining in adhered macrophages.

Immune
serum
————é*
Control
Inoculated
214,023
168,789
138,108
118,948
108,859
97,860
93,360
89,706
85,474
81,892
77,857

206,383
164,615
141,229
120,970
109,002
97,513
93,426
89,552
84,216
80,070
75,409

Table XII. The effect of various macrophage source/serum combinations on the rate of release of ^^Cr
from macrophages in cultures inoculated with F. tularensis strain Schu S4.

Normal
macrophages

Normal
serum

BCG immune
macrophages

Immune
serum

Normal
serum

2- t.- immune
macrophages

Immune
serum

Normal
serum

Immune
serum

Hours postinoculation

Contr. Inoc.

Contr. Inoc.

Contr. Inoc.

Contr. Inoc.

Contr. Inoc.

Contr. Inoc.

0
12
24
36
48
60
72
84
96
108
120

100.0* 100.0
79.3
82.6
72.6
74.8
66.0
67.1
61.0
55.5
56.5
41.6
53.4
30.3
51.7
25.0
49.0
22.8
45.0
20.2
41.0
16.8

100.0
78.3
69.5
62.6
57.3
54.0
50.0
47.1
45.7
43.7
40.0

100.0
77.6
66.4
60.9
55.3
51.8
48.1
47.3
46.5
44.3
42.1

100.0
81.9
70.4
62.9
57.0
51.8
45.6
44.2
43.6
42.5
40.7

100.0
73.7
68.1
59.8
54.4
50.7
48.0
45.7
42.8
39.2
36.8

100.0 100.0
78.9 79.8
64.5 68.4
55.6 58.6
50.9 52.8
45.7 47.2
43.6 45.3
41.9 43.4
39.9 40.8
38.3 38.8
36.4 26.5

Percent

100.0
80.4
73.2
57.5
42.1
28.2
19.8
16.3
14.5
11.4
8.5

Cr remaining in adhered macrophages.

100.0
81.3
72.0
65.1
56.5
41.2
26.4
21.0
19.0
16.7
14.1

100.0
80.7
66.2
48.3
26.4
15.4
10.4
9.2
7.9
6.4
4.7

100.0
74.2
68.5
61.6
55.7
50.6
47.2
44.7
41.9
37.7
34.6
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Fig. 11. Cytopathic effect of
tularensis strain Schu S4 on macrophages
harvested from normal mice, and cultured in medium containing
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Fig. 12.

Cytopathic effect of F^. tularensis strain Schu S4 on macrophages
harvested from mice immunized with viable BCG, and cultured in
medium containing normal vs immune rabbit serum. Inoculated • ;
noninoculated o ; normal serum in medium
; immune serum
in medium
.
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Cytopathic effect of IF. tularensls strain Schu S4 on macrophages
harvested from mice specifically immunized with viable
Z* tularensis, and cultured in medium containing normal vs
immune rabbit serum. Inoculated # ; noninoculated o; normal
serum in medium
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Experiment
culture.

- Growth of 2- tularensis strain S chu S4 in macrophage

This experiment was conducted to reconnoiter the growth kinetics
of the bacterium in this particular

vitro system.

Normal macro

phages, cultured in medium containing normal rabbit serum, were
inoculated with 2» tularensis strain Schu S4 at a ratio of approximately
10 bacteria per macrophage.
were inoculated.

Also, aliquots of culture medium alone

Bacterial growth curves were constructed by standard

plate count technique.
Typical results presented in Table XIII and Fig. 14 show that the
organism proliferated in the cell culture, however, the organism did
not grow in the culture medium alone.

Furthermore, the presence of

specific antibodies in the culture medium alone, had no bactericidal
effect of the organism.

Other in vitro studies of _F. tularensis

have obtained similar results (89).

Experiment 4. - Growth of 2- tularensis strain Schu S4 in cell-free
macrophage culture filtrate.
Corroborative studies, which have also demonstrated an assoc
iation between the presence of macrophages and bacterial growth in
cell culture, have presumed that this proliferation is a consequence
of intracellular multiplication (89,125).

In order to determine if

the bacteria are actually multiplying within the macrophage or
whether it might be multiplying outside of the macrophage as a result
of some possible secretory product or metabolite, serving as a
nutrient, growth, curves of the organism were conducted in cell-free
macrophage culture filtrates.
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Table XIII. Growth of
tularensis strain Schu 84 in macrophage
culture and in culture media.

Normal
macrophages
in medium
containing
normal serum

Cell-free
culture
filtrate
(normal serum)

Days postinoculation

Medium
containing
normal serum

0

4.1 X 10,4*

4.5

X 10*

4.4 X 10

4.3 X 10

1

4.3 X 10

4.3 X 10^

4.5 X 10

2.8 X 10-

2

3 . 8 X 10

4.7

X 10^

3.9

9.7

X

10'

3

4.2 X 10

4.5

X 10^

1.2 X 10

7.9

X

10,8

Medium
containing
immune serum

X 10'

8

^Number of bacteria per ml.
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Fig. 14,

Growth curves of K tularensis strain Schu S4 in culture media
and in macrophage culture. Medium & normal serum #
#;
medium & immune serum e
# ; normal macrophages & normal
serum o
o ; cell-free culture filtrate O
o.
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Macrophages were harvested from normal mice and cultured in medium
containing normal rabbit serum.

After 3 days of incubation, the

culture medium was withdrawn and filtered through a 0.22/im syringemounted Millipore^filter.
with

Aliquots of the filtrate were inoculated

tularensis strain Schu S4 and bacterial growth curves were

constructed.

The results presented in Table XIII and Fig. 14 show

that the bacteria proliferated in the absence of intact macrophages.

Experiment _5. - Effect of various macrophage source/serum combinations
on the growth of
tularensis strain Schu S4 in cell culture.
Macrophage cultures were set up as diagrammed in Fig. 1 and
inoculated with IF. tularensis strain Schu S4.

Bacterial growth

curves were then constructed.
Table XIV and Fig. 15 show the data from a typical experiment.
Although the type of serum in the culture medium had no effect on the
growth of the organism when the organism was inoculated in medium
alone (Expt. 3), there was a significant difference when macrophages
were present in the medium.

Presence of specific antibodies in

inoculated cell cultures suppressed bacterial growth.

The only

combination capable of completely inhibiting bacterial growth was
macrophages harvested from

tularensis immune mice, and cultured in

medium containing immune serum.

Table XIV. Effect of various macrophage source/serum combinations on the growth of
strain Schu S4 in cell culture.

Normal
macrophages
Days postinoculation

Normal
serum

BCG immune
macrophages

Immune
serum

Normal
serum

Immune
serum

tularensis

F. tularensis
immune
macrophages
Normal
serum

Immune
serum

0

4.3 X 104*

4.0 X 104

4.2 X 104

4.5 X 104

3.9 X lo4

4.2 X 10^

1

4.2 X 10^

4.1 X lO'^

4.6 X 10^

4.0 X 10^

4.4 X 10^

3.9 X 10^

2

4.8 X 10^

1.8 X 10^

7.6 X 10*

9.7 X 104

2.6 X 10*

3.9 X 10^

3

1.5 X 10®

3.7 X 10^

3.3 X 10®

5.1 X 10^

3.8 X 10^

3.8 X lo'^

^Number of bacteria per ml.

Type of
macrophage
in culture

Type of
serum in
culture

Activated
Normal

Normal
Normal

Immune

Normal

Normal

Immune

Activated

Immune

Immune

Immune
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Fig. 15.

Effect of macrophage source/serum combinations on the growth of jF. tularensis
strain Schu S4 in cell culture.
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In vivo uptake of 2- tularensls strain Schj S4 and
mouse peritoneal cells

monocytogenes by

Evidence has been accumulating which indicates that this organism
may not be phagocytosed by peritoneal macrophages.

Further investigat

ion was conducted by determining the iji vivo clearance of bacteria
from the peritoneal cavity of mice.
strain Schi S4 or
cavities of mice.

Suspensions of F^. tularensis

monocytogenes were injected into the peritoneal
One hr after injection, the peritoneal cavities

were lavaged and the exudates were separated into a cellular fraction
and a supernatant fraction by centrifugation.

In each case, the number

of cell-associated or supernatant-associated bacteria was assayed.

The

data have been presented in Table XV as the percent total recoverable
bacteria.

It was found that Ij. monocytogenes became associated with

the cellular fraction of the peritoneal exudate, whereas, F^. tularensis
remained with the fluid fraction.
To determine if antitularensis antibodies may be functioning as
opsonins, groups of mice were injected with F^. tularensis strain Schu
S4 which had been pretreated with immune rabbit serum.

The bacteria

were incubated in the immune serum at 37 ®C for 1 hr before ip.
injection.

This incubation was conducted at a prozone concentration

of antibody to prevent bacterial agglutination.

Likewise, bacteria

were incubated in normal rabbit serum to serve as controls.
are presented in Table XV.

Results

Pretreatment of the bacteria with specific

antibodies caused a significant fraction of the inoculum to become
cell-associated.

Little interaction was noted between peritoneal

cells and bacteria pretreated with normal rabbit serum.
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Table XV. In vivo uptake of F^. tularensis strain Schu S4 and
L. monocytogenes by mouse peritoneal cells .

of total number of organisms recovered

Challenge organism

Cell
associated

Supernatant
associated

7.0 ± 4.3

93.0 ± 4.3

96.0 ± 1.2

4.0 ± 1.2

_t. Schu S4 pretreated
with normal rabbit serum

3.6 ± 1,0

96.4 ± 1.0

2» _t. Schu S4 pretreated
with immune rabbit serum

21.8 ± 9.8

78.2 ± 9.8

2" _t. Schu S4
L. monocytogenes

^Mice were challenged ip. One hour later their peritoneal cavities
were lavaged, and the exudate separated into a supernatant fraction
and a cellular fraction by centrifugation.
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Exploratory studies were conducted to determine if strains of
F. tularensis of differing virulences might differ in their association
with the peritoneal cells or fluid.

It was found that there was no

significant difference in bacterial uptake attributable to the
virulence of the organism (data not presented).
An exploratory experiment was also conducted to in/estigate the
possibility that F^. tularensis strain Schu S4 contained an antiphago
cytic substance.

This was done by injecting a mixed inoculum of

Z* tularensis strain Schu S4 and L. monocytogenes and determining if
the presence of _F. tularensis would modify the uptake of the Listeria.
Bacterial plate counts of the respective exudate fractions were
performed on a selective medium which did not support the growth of
Z* tularensis.

It was found that the uptake of

monocytogenes

by mouse peritoneal cells was not altered by the presence of
F. tularensis strain Schu S4 (data not presented).
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Fluorescent antibody staining of macrophages in cultures inoculated
with 2' tularensis strain Schix S4
The existence of any intracellu larly-located bacteria was
probed by the use of fluorescein isothiocyanate-conjugated antitularensis immunoglobulin.

As positive controls, macrophage

cultures were inoailated with suspensions of formalin-killed
Coxiella burnetii and incubated for 2 days.

The cultures were

then washed 3 times with sterile saline, fixed in acetone at -70
for at least 12 hr and stained with a homologous fluorescent
conjugate.

The presence of

burnetii antigen within the cells

was readily detected (Fig. 15).
Macrophage cultures were inoculated with F. tularensis strain
Schu S4 and incubated until cytopathology was apparent.
were processed as described above and stained.

The cells

Fluorescent micro

scopic examination did not reveal the presence of the organisms
within the macrophages (Fig. 16).

There was considerable fluor

escence, however, along the external periphery of the cells.
Staining of cells in noninoculated cultures showed that this
peripheral fluorescence was not due to nonspecific adherence of the
conjugate to the macrophage cell membrane.
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Fig. 16i

Mouse peritoneal adherent cells maintained in KPMI
medium containing 20% rabbit serum, 2 days after
exposure to formalin-killed C^. burnetii, stained by
fluorescent antibody technique, showing intracellular
localization of antigen. 750X.

Fig. 17.

Mouse peritoneal adherent cells maintained in RPMI
medium containing 20% rabbit serum, 2 days after
exposure to viable 2- tularensis strain Schu S4,
stained by fluorescent antibody technique, showing
the absence of intracellular localization of the
organisms. 1250X.
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CHAPTER IV
DISCUSSION

The results obtained in this investigation indicate that
Francisella tularensis is in extracellular association with host
mononuclear phagocytes during the disease process in the mouse.

The

first line of evidence supporting an extraphagocytic nature of this
organism is its indif ference to an increased bactericidal capacity
of an activated RES.

In this study, viable BCG was used to activate

macrophages and to induce nonspecific resistance.

It has been shown

that this induction resulted in significant increases in protection
against known facultative intracellular parasites, but not against
2" tularensis strain S chu S4.

If _F. tularensis is such an intra

cellular parasite, it is inconceivable that the increased bacter
icidal capacity of the activated macrophages, which resulted in
over a 10^-fold increase in protection against challenge of mice
with I^. monocytogenes, should not be able to even mitigate tularemic
infection.
Further evidence which indicates an extraphagocytic nature of
this organism is its lack of association with mouse peritoneal cells
in vivo.

I^. monocytogenes is known to be a facultative intracellular

organism.

As expected, L. monocytogenes became associated with the

cellular portion of the exudate when injected into the peritoneal
cavities of mice.

£. tularensis strain Schu S4, however, remained

with the fluid portion of the exudate.

Taplits and Myrvik (124)

obtained similar results using F. tularensis strain LVS.

These

findings tend to suggest that an antiphagocytic substance might be
present on the bacterial cell wall.

Proctor e^

(102) assessed

phagocytosis of 2- tularensis by rhesus monkey peripheral poly
morphonuclear neutrophils (PMN) by the use of autoradiography,
electron microscopy and biochemical techniques.

They reported that

F^. tu larensis was not ingested by PMN in the absence of immune serum
and considered the possibility that this evasiveness was due to an
antiphagocytic substance on the surface of the bacterium.
unable to establish the existence of such a substance.

They were

In this

laboratory, attempts to demonstrate an antiphagocytic substance were
also unsuccessful.

The presence of 2- tu larensis strain Schu S4 did

not modify the uptake of 1^. monocytogenes by mouse peritoneal cells
in vivo.
Additional evidence of lack of intraphagocytic occurrence of
2. tularensis strain Schu S4 was obtained by direct fluorescent
microscopic examination of inoculated cultures.

Fluorescent antibody

staining of moribund peritoneal macrophages in inoculated cultures
did not reveal the presence of intracellular antigen.

Demonstration

of intracellular C^. burnetii antigen with a homologous conjugate
indicates that this technique was capable of detecting antigens so
located.

Also, staining of bacterial smear controls showed that

the conjugate did indeed have a specificity for 2* tularensis.

A

fluorescent haze was observed along the external periphery of
numerous macrophages.

It was found that this was not due to non

specific adherence of the conjugate to the macrophage.

Functional

testing of macrophages by latex particle ingestion revealed that
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these cells were avidly phagocytic.

Adherence of bacteria to

macrophages without subsequent ingestion would be intriguing.

Such

an occurrence, however, would be inimical with the results obtained
in the in vivo uptake experiment.

A similar phenomenon was reported

by Merriott et al. (85) in F. tularensis-inE ected mouse L cells.
They noted that this occurrence was influenced by the concentration
of serum in the culture medium.

The effect of serum concentration

was not investigated in this study.

Although the observance of

peripheral fluorescence requires more investigation, emphasis is
placed on the fact that the organisms were not detected inside of
the macrophages.

Other studies, however, have detected

tularensis

within various types of host cells by means of fluorescent antibody
technique (55,85,134).
From the results of this study alone, an assertion that
_F. tularensis strain Schu S4 is a strict extracellular parasite would
be an unwarranted generalization.
association by

The evidence of extracellular

tularensis presented in this investigation may

apply only to mouse peritoneal macrophages.

It is quite possible

that the phagocytic avidity of mouse peritoneal macrophages for
F. tularensis strain Schu S4 may differ from other animal species, or
even from other cell types within the mouse.

Extrapolation to other

animal models and/or cell systems may not be supportable.

All the

evidence presented in this study, however, indicates that 2* tularensis
strain Schu S4 is in extracellular association with mouse peritoneal
macrophages.
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Scientific literature contains numerous references which are
responsible for the belief that
intracellular parasite.

tularensis is a facultative

Nutter and Myrvik (89) repordetly have

grown the organism in cultured alveolar macrophages.

Thorpe and

Marcus (125) infected cultures of alveolar and peritoneal macro
phages from rabbits and guinea pigs with various strain of
2" tularensis and observed the bacteria within the cultured cells.
Proctor ^

(102) incubated rhesus monkey peritoneal macrophages

with %-labelled LVS organisms and observed intracellular local
ization of the label.

White e_t

(134) have provided revealing

fluorescent photomicrographs of monkey alveolar macrophages
containing 2- tularensis strain Schi S4 in the cytoplasm of the
phagocytes.
It mist be stated that, although there is good evidence of an
intraphagocytic nature of this organism in animal species other than
the mouse and in cell types other than peritoneal cells, such e/idence
is scanty as far as the mouse peritoneal macrophage system is
concerned.

The possibility of a unique phagocytic avidity among

mouse peritoneal macrophages has been suggested by Thorpe and Marcus
(126).

Findings presented in this study are not inconsistent with

the literature.
Studies which have been cited in support of an intracellular
nature of this organism have often been presumptuous in assuming that
bacterial proliferation and cytopathology are a consequence of intra
cellular multiplication.

Nutter and Myrvik (89) inoculated

suspensions of rabbit peritoneal macrophages with E^. tularensis
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strain Schu S4 and noted that the bacteria proliferated.

They

stated that this increase was "most probably" the result of intra
cellular multiplication.

Actual phagocytosis of the bacteria has

often only been inferred, rather than proved.

Thorpe and Marcus

(125) determined the concentration of bacteria within phagocytes
in vitro, and also ingestion and digestion rates of the bacteria,
by light microscopy.

The small size (0.2-0.3 x 0.7y^m) and the

extreme pleomorphlsm of this organism, coupled with the granularity
of the macrophage cytoplasm, appears to this writer, and also to
others (83,102), to preclude identification of the organism within
phagocytes by conventional light microscopy.
Correlation has been dimonstrated in this study between bact
erial growth in cell culture medium and the presence of macrophages.
The In vItro system of Nutter and Myrvik (89) produced similar
findings.

An association between bacterial growth in cell culture

medium and the presence of macrophages does not necessarily imply
that the bacterial growth is occurring within the macrophage.

The

location of proliferation was investigated in this study by monitor
ing the growth of the organism in macrophage culture filtrates.

The

organism was found to grow in the cell-free culture filtrate as
luxuriantly as in the cell culture.

It is astonishing that none of

the studies reviewed by this writer have considered the possibility
of this occurrence.

Apparently, macrophages in this system released

some excretory product or metabolite which provided a growth
requirement for this fastidious bacterium.

The existence of such

extracellular macrophage products is well established (6, 97,117,
131,133).

Limited characterization of this factor was conducted.
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It was heat stable (56 ®C for 30 min).

Bacterial growth curves in

culture media containing varying dilutions of the filtrate were
constructed.

It was found that as the concentration of the filtrate

decreased, the rate of growth of the bacteria decreased and also
that the number of organisms eventually attainable decreased.

This

suggests that the nature of this factor is not vitamin-like, but
rather, that it may be a consumable product.

Further character

ization is beyond the scope of this investigation.

The important

point is that the correlation which can be shown between bacterial
proliferation and the presence of macrophages in this system, may
be explainable in terms of extracellular growth.
Numerous studies have recently been reported which also suggest
an extraphagocytic nature of this organism.

Proctor et al. (102)

found that F^. tularensis resisted phagocytosis by hi man, monkey and
rat PMN in vitro.

They postulated that this phagocytic evasiveness

deleted one of the possible host defense mechanisms and permitted
early dissemination of the organism to specific target tissues.
Taplits and Myrvik (124) observed that Listeria were rapidly
eliminated from the peritoneal ca/ity of nice challenged ip.,
whereas F. tularensis strain LVS maintained a steady state population.
They suggested that F^. tu larensis may be able to grow extracellularily
and eventually overcome the host defense machanisms.

Powanda et al.

(99) studied metabolic sequelae induced in rats by infection with
2. tu larensis strain Schu S4.

They concluded that

in nonimmune rats eludes the RES."

tu larensis
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The subject of tumoral iiwolvment in resistance to tularemia
remains an area oE controversy.

Specific antibodies havre generally

been believed to be only of secondary importance in imnunity to
murine tularemia.

Passive transfer of serum from resistant mice has

repeatedly failed to protect normal recipients against challenge with
fully virulent strains of 2- tularensis (70,80).

Claflin (20) found

that specific immune serum from mice imnunized with LVS was incapable
of protecting mice from even a low challenge dose of 2- tularensis
strain Schu S4.

Hirthermore, increasing the titer and the quantity

of the antiserum did not produce resistance, and led him to conclude
that "specific antibodies, per se, are not of primary importance in
immunity to tularemia."

Also, opsonization of the bacteria prior

to challenge was not found to increase resistance.

Peckinpaugh (95)

observed that although comparable levels of antibodies were present
in groups of mice immunized with nonviable and viable vaccines, the
resistance of the 2 groups of mice to infection with fully virulent
strains of

tularensis was not comparable.

Thorpe and Marcus

(125,126) reported that the type of serum (normal vs immune) in
cell culture media did not significantly affect the ingestion of
F. tularensis by rabbit or guinea pig peritoneal macrophages in
vitro.

Similar findings were reported by Natter and Myrvik (89).

Serum antibodies are not always an indication of the Immine state.
Studies cited in the preceeding paragraph discount the import
ance of hi moral immunity in host resistance to infection with
2' tularensis.
findings.

The resuIts presented here, conflict with those

This study presents evidence that antitularensis isnauno-
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globulins may have an important role in the expression of immunity
in mice.

This may seem in contradiction with the finding that the

establishment of a specific humoral response in mice by active or
passive immunization did not alter the course of infection by
Z.' tailarensis strain Schu S4, a finding in agreement with numerous
other studies (20,21,95).

However, further investigation revealed

some interesting insights.

In conjunction with an activated RES,

specific antibodies resulted in measurable protection against
challenge with 2- tu larensis strain Schu S4.

luoma (70,71)

conducted similar experiments with 2- tularensis strain 425 F^G
and also found that a combination of humoral and cellular factors
resulted in protection.

This increase in protection was only minor,

and of no practical significance to the host, but, nevertheless, it
does indicate that antibodies may participate in an immune response
to this organism.

The finding that the presence of specific anti

bodies in cell culture media resulted in differences in cytopathology
of mouse peritoneal macrophages in inoculated cultures also indicates
humoral involvement.

Destruction of normal and BCG imraine macrophages

by F. tularensis strain Schu S4 was greater when the cultures
contained media with immune serum.

This finding was unexpected.

It

is interesting that specif ic antibodies can be shown to increase the
susceptibility of host cells to a pathogen.
later.

This will be discussed

Antibody involvement was also indicated by an inhibitory

effect of immune serum on bacterial growth in cell culture.

When

bacteria were inoculated into medium in the absence of macrophages,
it was found that the immune serum in the culture medium did not
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inhibit bacterial growth any more than normal serum.

When macro

phages were present in the culture medium, however, immune serum
resulted in a

general suppression of bacterial growth in comparison

with normal serum.

Although there are indications of a protective

action of antibodies during tularemic infection in mice, the exact
nature of this interaction is uncertain.
Other studies have also challenged the contention that anti
bodies are unimportant in resistance to tularemia.

Luoma (70,71)

found that cyclophosphamide, an immunosuppressive agent effective
in eliminating the antibody producing cell, abolished immunity to
2. tularensis strain 425 F^G.

She concluded that immunity to

Z' tularensis results from a conbination of specific and nonspecific
immunity.

Proctor et al. (102) found that specific antibodies were

required for the phagocytosis of 2' tularensis by human, monkey and
rat PMN.

Taplits and Myrvik (124) monitored the growth of

F. tu larensis strain LVS in the organs of infected mice and found
that the decline of the LVS population in these mice coincided with
the appearance of specific agglutinins.

Eigelsbach et al. (35)

showed that adaptive transfer of spleen cells from Schu S4 vaccinees
was often protective only when antitularensis serum was also admin
istered.
In this study, evidence has been obtained which suggests that
the antibodies may be activg as opsonins.

It was found that the

presence of immune serum in the medium of inoculated cultures
increased the destruction of nonimmune macrophages by the bacteria.
A similar phenomenon was also observed by Thorpe and Marcus (126).
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One possible explanation is that the antibodies opsonized the bacteria.
Opsonization resulted in the phagocytosis of the bacteria by the
macrophages.

Hav'ing been phagocytosed, the bacteria were placed in

a position where the phagocytes were more vulnerable to the cytocidal
activity of the bacteria.

It was also found that immune serum

enabled the macrophage cultures to more effectively inhibit the
growth of this organism in cell cultures.

Bacterial growth was

suppressed in cultures containing immune serum.

The growth curves

of the organism in medium containing normal vs immune serum without
macrophages, demonstrated that this suppression was not due to
complement-mediated bacteriolysis.

Considering the findings that;

1.) the organisms were not detectable within the cells of inoculated
macrophage cultures containing normal serum, 2.) the organisms were
capable of extracellular proliferation in such cultures, and that
3.) specific antibodies by themselves were not deleterious to the
viability of the organism, the suppression of bacterial growth in
cell cultures containing immune serum could be explained by reason
ing that the specif ic antibodies functioned as opsonins and resulted
in the engulfment of the bacteria into the unfavorable en/ironment
within the phagocyte.

Pretreatment of bacteria with homologous

antibodies increased bacterial association with peritoneal cells
in vivo.

This confirms findings by Taplits and Myrvik (124).

Although this increase was not as dramatic as hoped, it is statis
tically significant.
Other evidence exists which also supports an opsonic nature of
antibodies in the immune response to tularemic infection.

Claflin (20)
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found that the clearance of virulent tularemia bacilli from the
blood of mice was enhanced when specific antibodies were passively
into the mice.

Proctor ^

(102) demonstrated that immune

serum enabled monkey PMN to engulf F^. tularensis in vitro.

Taplits

and Myrvik (124) reported that mice had difficulty in removing
Z.' tularensis strain LVS from the peritoneal canity before the
appearance of specific antibodies.
Resistance to tularemia has been shown to be dependent on a
state of altered reactivity of the host cells.
this investigation confirm that dependency.

Results obtained in

The exact mechanism by

which host cells become specifically sensitized and exert antibact
erial properties is still undefined.

Only macrophages harvested

from mice specifically immunized with viable tularemia organisms
were found to be resistant to the cytopathic effect of F. tularensis
strain Schi S4.

Also, only macrophages from this source were capable

of completely inhibiting bacterial growth.

Macrophages from other

sources apparently lacked some specific, altered, intrinsic quality.
Immunization with a non/iable antigen did not result in protect
ion against challenge by fully virulent strains of %. tularensis.
Van der Meer

(130) suggested that the inability of nonviable

vaccines to protect against some infections may be due to rapid and
extensive digestion of the antigen.

They found that complete

digestion of previously killed Listeria did not result in protection,
but that this non/iable vaccine became protective when macrophage
activity was impaired by the addition of polyanions.

Incomplete

processing of nonviable antigens could result in continued antigenic
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stimulation and may be a prerequisite for protection.
The experiment which was conducted to investigate the effect
of various macrophage source/serum combinations on the growth of
jF. tularensis strain Schu S4 in cell culture produced some revealing
results which may serve to clarify and unite the results obtained
elsewhere in this study.

It was found that macrophages harvested

from resistant mice were able to suppress bacterial growth only
when specific antibodies were present in the system.

It was only

these macrophages which posessed the forementioned ability to
inactivate ingested organisms.

Although these phagocytes had the

ability to destroy the organisms* this ability was ineffectual,
unless antibodies were available to opsonize the organisms.

In

the absence of antibodies, the bacteria may not be ingested, and
proliferate extracellularily and escape intraphagocytic destruction.
In the presence of antibody, the bacteria are presumable opsonized
and thereby placed in a position where inactivation can occur.
Immunity of mice to

tularensis strain Schu S4 thus appears to

require specific sensitization of reticuloendothelial cells.
enables the host to inactivate the organism.
also require specific antibodies.

This

Immunity appears to

These are necessary to expose the

organisms to the bactericidal machinery in the intracellular
environment of the sensitized macrophage.

With this in mind: 1.)

the inability of viable BCG to induce nonspecific immunity effective
against challenge with this organism can be explained by reasoning
that specific antibodies were absent; 2.) the inability of active
immunization with EEA or passive administration of immune serum to
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result in protection against infection can be explained by reasoning
that the macrophages lacked the functional capacity to inactivate
the ingested bacteria; 3.) the protection which resulted from the
combination of RES activation and humoral immunity can be explained
by reasoning that the specific antibodies opsonized the bacteria
and exposed them to the increased bactericidal properties in the
intracellular environment of the BCG activated macrophages; 4.) the
finding that the susceptibility of normal and BCG immune macrophages
to bacterial cytopathology was greater in cultures containing
immune serum than in cultures containing normal serum can be
explained by reasoning that the specific antibodies in the immune
serum positioned the bacteria in a location where the macrophages
are more vulnerable to the cytocidal activity of the bacteria and
finally, 5.) inhibition of bacterial growth in macrophage culture
can be expected to occur only in cultures containing immune serum
and cells harvested from mice specifically immunized with viable
organisms.
The cytopathology which was noted in inoculated cultures
should be accountable.

Intracellular bacterial proliferation

leading to rupture of the macrophage is improbable in light of the
lack of any evidence of intracellular existence of the organisms in
this cell type (in the absence of opsonins).
directed against the macrophage is indicated.

Some bacterial factor
F^. tularensis is not

known to produce any toxins, although there are reports that viable
tularensis organisms have toxic properties (11,39,64,88,89).
Bacterial lipopolysaccharides are known to be cytotoxic to macrophages
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however, no classical endotoxin has been demonstrated in _F. tularensis.
The possibility of a bacterial product toxic to macrophages in this
system was briefly investigated by adding cell-free bacterial culture
filtrates to macrophage cultures and observing for any resulting
cytotoxicity.

^^Cr-release methodology showed that this bacterial

culture filtrate did have a slight cytotoxic effect on the cultured
macrophages.

Due to a time limitation, further investigation was

not conducted.

Clearly, more research into this matter would be in

order.
Although the phagocytic leucocyte has been implicated as the
receptor cell for many facultative intracellular bacteria, evidence
presented in this study indicates that this may not be the case
regarding

tularensis strain Schu S4 in the mouse.

Tularemic

lesions, including hemorrhagic necrosis of the spleen, focal necrosis
of the liver and widespread degenerative tissue changes, clearly
indicate cellular destruction in the disease process.

tularensis

is known to infect various cell types on non-lymphoid origin.
Merriott £t

(85) found that ]F. tularensis strain Schu S4 was

highly infectious for mouse L cells, bovine kidney cells and human
amnion cells

vitro, and that rapid bacterial multiplication

occurred in the cytoplasm of these various cells.

Powanda et al.

(99) maintain that ]?. tularensis strain Schu S4 in nonimmune rats
infects the parenchymal cells of the liver and spleen.

Hall et al.

(55) and White ^ al. (134) challenged rhesus monkeys with aerosols
of F. tularensis and demonstrated by immunofluorescence that the
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organisms were present in the epithelial cells of the respiratory
bronchioles and adjacent alveoli.

Downs e^ a^. (29) have shown

that the organisms multiply abundantly in the tissues of embryonated
chicken and duck eggs.

Shepard (114) has shown that 2' tularensis

is engulfed by HeLa cells.

It may well be that such non-lymphoid

cells comprise the primary target tissues in the disease process
during tularemia in the mouse.
The anomalies between the ^ vitro findings in this study and
other similar studies may be due, in part, to variable inherent to
such in vitro systems.

Many studies have employed macrophages which

were obtained from inflammatory exudates stimulated by various types
of chemotactic agents or irritants.

The phagocytosis of organisms

by peritoneal macrophages has been shown to be influenced by these
procedures (24,3 8).

McElree and Downs (83) demonstrated that macro

phages exhibited a strikingly increased ability to ingest F. bilarensis
when irritants were used to elicit the exudates.

In this study,

however, non-inflammatory cells, harvested from untreated peritoneal
cavities, were used, so as to simulate more closely, the in situ
physiological state of the cells.

The source of animal serum best

suited for the culture and parasitization of phagocytes also remains
an open question (85).

Guinea pig and calf sera have been reported

to enhance significantly the phagocytosis of %. tularensis by
peritoneal macrophages

vitro, whereas, rabbit serum failed to

enhance ingestion oE the organisms (83).

Shepard (112) showed that

HeLa cells are more phagocytic and more susceptible to infection with
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tubercle bacilli when cultured in mediua containing horse serum
than in media containing human serum.

These variables might account

for the different results obtained in this study.
Virulence

factors of F. tularensis are obscure.

of this study shed little light on this issue.

The results

It appears, though,

that virulence can not be equated with the degree of association of
the organisms with host phagocytes.

In vivo uptake experiments

have shown that avirulent and virulent strains are equally dissociated
from mouse peritoneal macrophages.

Other studies which have used

cells capable of normally engulfing this organism have demonstrated
that strains of varying virulences are equally phagocytosed (85).

It

is personally felt that virulence may be a function of the organisms
metabolism and nutritional requirements.

Strains of reduced virulence

have been observed to grow more slowly on plate culture.

Plate counts

of such strains are lower and irregular and colonial characteristics
vary considerably.

Less virulent strains have also been noticed to

be more sensitive to their environment.

It is set forth that the

virulence of ]?. tularensis is not associated with phagocytic
evasiveness, but rather, that virulence of the organism parallels its
ability to persist and multiply in the host, either intracellularly
or extracellular ly.
Evidence has been presented in this investigation which
indicates that F^. tn larensis strain Schu S4 may not ordinarily be
ingested by reticuloendothelial cells in the nonimmune mouse.

Withr-

out phagocytosis, the organisms might be able to proliferate extra-
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phagocytically, disseminate to sites of specific target tissues and
eventually wercome other host defense mechanisms.
Resistance in mice to tularemic infection apparently reauires
the cooperation of both humoral and cellular immune mechanisms.
Host resistance may depend on the functional capacity of the host
cells to inactivate the organism.

Resistance may also require the

opsonic effect of specific antibodies so that inactivation can be
accomplished.
Host immunity, and survival of parasites, depend on a complex
and delicate balance of host-parasite interplay.

The mechanisms of

immunity which arise in the host to rid it of intracellular parasites
are not fully understood.

The results of this study, although

inconclusive, may serve to clarify some of the enigmas which have
persisted over the years regarding host-parasite interaction during
tularemia.

CHAPTER V
SUMMARY

This study has presented evidence which indicates that
K' tularensis is in extracellular association with host mononuclear
phagocytes during the disease process in the mouse.
infection of mice with

The course of

tu larensis strain S chu S4 was not mitigated

by the increased bactericidal capacity of a BCG activated RES.

When

injected into the peritoneal canity of mice, _F. tu larensis strain
Schu S4 became associated with the fluid portion of the peritoneal
exudate, whereas, I^. monocytogenes, when injected ip. became assoc
iated with the cellular portion of the exudate.

Fluorescent anti

body staining of macrophage cultures inoculated with _F. tularensis
strain Schu S4 did not reveal the presence of intracellular
organisms.

This evasiveness does not appear to be due to an anti

phagocytic substance on the bacterial cell surface.

It is

postulated that in the nonimmune mouse, 2- tularensis strain Schu
S4 may not ordinarily be ingested by phagocytes and may be able to
w ercome host defenses while in extracellular association with the
host.
Contrary to the generally-held belief that specific antibodies
ar only of secondary importance in immunity to tularemia, evidence
is presented in this study which indicates that antibodies may have
a vital role in resistance in mice.

Humoral immunity in conjunct

ion with a nonspecifically activated RES resulted in a degree of
protection against challenge with F. tularensis strain Schu S4.

81
^^Cr-release assays showed that immune serum influenced the
cytopathic effect of
macrophages.

tularensis strain Schu S4 on cultured

Pretreatment of bacteria with immune serum increased

their association with peritoneal cells in vivo.

Cultured macro

phages were able to suppress bacterial growth only when specific
antibodies were present in the culture medium.

Specific anti

bodies may function in host resistance by promoting phagocytosis
and controlling dissemination of the infecting organisms.

Resistance in mice to tularemic infection appears to require
the synergistic cooperation of both humoral and cell-mediated
mechanisms of imnunity.

Cellular sensitization is required for

inactivation of the organisms.

Specific antibodies are also

necessary to aid ingestion, so that inactivation can occur.
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